Skip to main content

Table 5 Affordability of anticancer medicines by high, middle and low-income class patients in Punjab, Pakistan

From: Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan

Sr. No. Medicine and Dose OB Overall OB LPG Overall LPG Overall both (OB + LPG)
High Middle Low High Middle Low
1 Anastrozole 1 mg tab 100 50.1 18.3 71.5 100 68.3 20.6 63.2 68.2
2 Bicalutamide 50 mg tab 100 28.2 12.4 48.9 100 100 73.8 93.3 66.4
3 Bleomycin 15 mg inj 68.3 18.1 6.5 27.8 78.8 46.6 15.4 46.9 36.0
4 Capecitabine 500 mg tab 61.9 25.0 8.1 35.5 NA NA NA NA 35.5
5 Carboplatin 150 mg inj 100 93.1 32.7 79.3 100 100 77.1 93.6 85.0
6 Cisplatin 50 mg inj 100 100 60 91.6 100 100 97.5 99.3 94.4
7 Cyclophosphamide 500 mg inj 100 65.5 28.0 70.5 100 95.9 57 86.6 77.0
8 Cyproterone Acetate 50 mg tab 100 99.5 43.8 84.5 NA NA NA NA 84.5
9 Cytarabine 100 mg inj 100 100 69.9 92.5 100 100 100 100 94.7
10 Dacarbazine 200 mg inj 100 77.8 53.6 78.3 100 100 67.9 90 83.4
11 Dactinomycin 0.5 mg inj 100 42.6 14.7 66.1 100 51.8 17.8 56.4 62.3
12 Daunomycin 20 mg inj 100 50.3 15.7 58.1 100 100 43.3 85.6 69.0
13 Docetaxil 80 mg inj 31.8 5.5 3.2 15.1 NP NP NP NP 15.1
14 Doxorubicin 50 mg inj 100 62.5 27.8 68.7 100 93.5 39.5 80.3 73.0
15 Epirubicin 50 mg inj 75.3 28.6 9.0 44.2 96.4 38.1 19.1 55.3 48.6
16 Etoposide 100 mg inj 100 77.4 31.0 74.6 100 92.4 43.9 82.1 77.6
17 Fludarabine phosphate 50 mg inj 30.1 8.2 2.8 15.9 40.3 11.1 5.1 2.7 17.8
18 Flourouracil 500 mg inj 100 100 60.9 90.6 100 100 100 100 94.4
19 Gemicitabine 1 g inj 21.3 9.7 3.5 13.2 32.4 13.5 5.2 18.1 15.1
20 Hydroxyurea 500 mg cap 100 100 100 100 NP NP NP NP 100
21 Ifosfamide I gminj 62.9 29.5 9.1 42.3 62.9 29.2 8.8 33.5 38.8
22 Imatinibmesylate 400 mg tab 7.2 2.4 0.8 3.6 NA NA NA NA 3.6
23 Irinotecan 100 mg inj 6.7 2.2 1.0 3.8 11.6 4.4 2.1 6.5 4.9
24 Lapatinib 250 mg tab 8.0 3.0 1.0 5.1 NA NA NA NA 5.1
25 Letrozole 2.5 mg tab 86.5 40.7 12.6 58.3 100 68.7 20.7 63.3 60.3
26 Mercaptopurine 50 mg tab 100 100 100 100 100 100 100 100 100
27 Methotrexate 10 mg tab 100 100 100 100 100 100 100 100 100
28 Mitomycin 10 mg inj 100 100 48.5 89.2 100 100 100 100 93.5
29 Mitoxantrone 20 mg inj 100 100 52.5 90.1 NA NA NA NA 90.1
30 Nilotinib 200 mg cap 2.2 0.9 0.3 1.4 NA NA NA NA 1.4
31 Oxalplatin 100 mg inf 14.5 5.8 2.0 8.2 18.0 6.6 3.5 10.3 9.1
32 Paclitaxel 260 mg inf 23.9 8.5 4.6 15.6 23.9 14.6 5.0 14.5 15.1
33 Pazopanib 400 mg tab 14.8 3.5 1.4 6.8 NA NA NA NA 6.8
34 Sorafenib 200 mg tab 6.3 3.2 1.1 4.3 NA NA NA NA 4.3
35 Sunitinib 50 mg cap 6.7 1.6 0.6 3.1 NA NA NA NA 3.1
36 Tamoxifen 20 mg tab 100 100 100 100 100 100 100 100 100
37 Thalidomide 100 mg cap 100 67.7 24.3 75.1 NA NA NA NA 75.1
38 Vinblastine 10 mg inj 100 43.2 15.6 50.5 100 100 43.9 81.3 63.7
39 Vincristine 2 mg inj 100 100 85.2 96.3 100 100 99.4 99.8 97.6
40 Vinorelbine 50 mg inj 100 8.7 4.8 54.6 100 15.1 5.1 39.2 48.5
Total 70.7 49.1 29.2 53.4 84.4 69.6 49.0 67.9 55.5
  1. OB = Originator brand; LPG = Lowest price generic; NA = Not available; NP: Not prescribed